United States · FDA National Drug Code directory
Zycubo
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 42358-329_bfd40890-37a6-4847-9b2d-6e6966b6af01
- Product NDC
- 42358-329
- Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Composition / generic term
- copper histidinate
- Labeler
- Sentynl Therapeutics, Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20260112
- Source listing expiry
- 20271231
Source-listed ingredients
- COPPER HISTIDINATE — 2.9 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL, GLASS in 1 CARTON (42358-329-01) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, GLASS · 42358-329-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →